A favorable outcome of intensive immunotherapies for new-onset refractory status epilepticus (NORSE)
Abstract Background New-onset refractory status epilepticus (NORSE) is a newly defined critical disease entity characterized by prolonged periods of refractory epileptic seizure with no readily identifiable cause in otherwise healthy individuals. Its etiology is uncertain, but autoimmune encephaliti...
Main Authors: | Satoshi Kodama, Noritoshi Arai, Akiyoshi Hagiwara, Akio Kimura, Sousuke Takeuchi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-07-01
|
Series: | Journal of Intensive Care |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40560-018-0315-7 |
Similar Items
-
New-Onset Refractory Status Epilepticus (NORSE): literature review and clinical case description
by: S. G. Burd, et al.
Published: (2020-11-01) -
‘The great imitator’: Neurosyphilis and new-onset refractory status epilepticus (NORSE) syndrome
by: Sonia Kumari, et al.
Published: (2015-01-01) -
New-Onset Refractory Status Epilepticus Mimicking Herpes Virus Encephalitis
by: Gianfranco Puoti, et al.
Published: (2013-09-01) -
Treatment of Refractory Status Epilepticus
by: J Gordon Millichap
Published: (2008-07-01) -
Study of refractory status epilepticus from a tertiary care center
by: Sahil Kohli, et al.
Published: (2017-01-01)